Back to Market Feed

Product Information

FT NAPROXEN SODIUM 220 MG CAP is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1507 per EA under NDC 70677114801. Its NADAC has been published 146 times since Nov 8, 2023.

FDA first approved this application on Mar 15, 2018.

FT NAPROXEN SODIUM 220 MG CAP

Naproxen Sodium
$0.1507per EA
OTC

Strength

220 mg/1

NDC

70677114801

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

NAPROXEN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA208363

FDA Approved

3/15/2018

On Market Since

3/31/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT NAPROXEN SODIUM 220 MG CAP has been published 146 times since Nov 8, 2023, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1507 per EA
All-time high$0.1734 (Dec 13, 2023)
All-time low$0.1331 (Jul 23, 2025)
52-week high$0.1513
52-week low$0.1391
Median price$0.1489
Average price$0.1490
Largest weekly change-12.1% (Dec 20, 2023)
Weeks tracked146
Tracking sinceNov 8, 2023

Price History

1W

-0.4%

1M

-0.4%

3M

+2.9%

6M

+4.5%

1Y

+8.4%

3Y

N/A

5Y

N/A

All

-13.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

MINIPRIN EC 81 MG TABLET
Generic
49483033010•Time-Cap Labs Inc.
$0.0118
per EA
MINIPRIN EC 81 MG TABLET
Generic
49483033012•Time-Cap Labs Inc.
$0.0118
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035203•Chain Drug Marketing Association
$0.0121
per EA
QC ASPIRIN 325 MG TABLET
Generic
63868035210•Chain Drug Marketing Association
$0.0121
per EA
ST. JOSEPH ASPIRIN EC 81 MG TB
Generic
69536018112•Foundation Consumer Healthcare LLC
$0.0139
per EA
ASPIRIN EC 81 MG TABLET
Generic
00536123441•Rugby Laboratories
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904675180•Major Pharmaceuticals
$0.0146
per EA
ASPIRIN EC 81 MG TABLET
Generic
00904678370•Major Pharmaceuticals
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059848•AmerisourceBergen
$0.0146
per EA
GNP ASPIRIN EC 81 MG TABLET
Generic
46122059887•AmerisourceBergen
$0.0146
per EA

Frequently asked questions

What is the NADAC price of FT NAPROXEN SODIUM 220 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for FT NAPROXEN SODIUM 220 MG CAP, manufactured by Strategic Sourcing Services LLC, is $0.1507 per EA (NDC 70677114801), effective Aug 19, 2026.

How has the price of FT NAPROXEN SODIUM 220 MG CAP changed over time?

Over the history we have for it, the NADAC for FT NAPROXEN SODIUM 220 MG CAP has declined 13.1%. It has been tracked across 146 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for FT NAPROXEN SODIUM 220 MG CAP?

Since Nov 8, 2023, the NADAC for FT NAPROXEN SODIUM 220 MG CAP has ranged from a low of $0.1331 (Jul 23, 2025) to a high of $0.1734 (Dec 13, 2023), with a median of $0.1489 per EA.

Are there cheaper alternatives to FT NAPROXEN SODIUM 220 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of FT NAPROXEN SODIUM 220 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FT NAPROXEN SODIUM 220 MG CAP?

FT NAPROXEN SODIUM 220 MG CAP (NDC 70677114801) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.